6-Mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 1, 2005, Pages 52-55

  Domènech, Eugeni ^a   Nos, Pilar ^b   Papo, Michel ^c   López San Román, Antonio ^d   Garcia Planella, Esther ^a   Gassull, Miquel A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Azathioprine; Crohn's disease; Immunomodulators; Inflammatory bowel disease; Mercaptopurine; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; IMMUNOMODULATING AGENT; MERCAPTOPURINE; STEROID;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; ALLERGIC REACTION; CLINICAL ARTICLE; CROHN DISEASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOXICITY; DRUG WITHDRAWAL; DYSPEPSIA; ENTERITIS; EPIGASTRIC PAIN; FEMALE; HEADACHE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NAUSEA; PRIORITY JOURNAL; REVIEW; SPAIN; THORAX PAIN; TREATMENT WITHDRAWAL; ULCERATIVE COLITIS; VOMITING;

6-MERCAPTOPURINE; ADULT; AZATHIOPRINE; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME;

EID: 12444317534     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410009492     Document Type: Review

References (11)

1. Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease (Cochrane review). In: The Cochrane Library, I. Oxford: Update Software; 2002.
2. Pearson DC, May GR, Pick G, Sutherland LR. Azathioprine for maintenance of remission in Crohn's disease (Cochrane review). In: The Cochrane Library, I. Oxford: Update Software; 2002.
3. George J, Present DH, Pou R, Bodian C, Rubin PH. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol 1996;91:1711-4.
4. Present DH, Meltzer SD, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989;111:641-9
5. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJG, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990;99:4443-6
6. Dejaco C, Mittermaier C, Reinisch W, Gasche C, Waldhoer T, Strohmer H, et al. Azathio prine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001;121:1048-53.
7. Mahmoud AEA, Willoughby JMT. Azathioprine and 6-mercaptopurine are not necessarily interchangeable in the treatment of Crohn's disease. Gastroenterology 1995;108:A868.
8. Bowen DG, Selby WS. Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine. Dig Dis Sci 2000;454:1810-3.
9. Boulton-Jones JR, Pritchard K, Mahmoud AA. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy. Aliment Pharmacol Ther 2000;14:1561-5.
10. Colombel J-F, Ferrari N, Debuysere H, Marteau P, Gendre J-P, Bonaz B, et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 2000;118:1025-30.
11. MGovern DPB, Travis SPL, Shobowale-Bakre EIM, Duley J, Dalton HR. Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity. Gastroenterology 2002;122:838-9.